Correlation Between Jindal Poly and Aarti Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jindal Poly and Aarti Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jindal Poly and Aarti Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jindal Poly Investment and Aarti Drugs Limited, you can compare the effects of market volatilities on Jindal Poly and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jindal Poly with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jindal Poly and Aarti Drugs.

Diversification Opportunities for Jindal Poly and Aarti Drugs

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Jindal and Aarti is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Jindal Poly Investment and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and Jindal Poly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jindal Poly Investment are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of Jindal Poly i.e., Jindal Poly and Aarti Drugs go up and down completely randomly.

Pair Corralation between Jindal Poly and Aarti Drugs

Assuming the 90 days trading horizon Jindal Poly Investment is expected to under-perform the Aarti Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Jindal Poly Investment is 1.35 times less risky than Aarti Drugs. The stock trades about -0.21 of its potential returns per unit of risk. The Aarti Drugs Limited is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  45,310  in Aarti Drugs Limited on September 26, 2024 and sell it today you would earn a total of  2,280  from holding Aarti Drugs Limited or generate 5.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Jindal Poly Investment  vs.  Aarti Drugs Limited

 Performance 
       Timeline  
Jindal Poly Investment 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Jindal Poly Investment are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Jindal Poly displayed solid returns over the last few months and may actually be approaching a breakup point.
Aarti Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest conflicting performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Jindal Poly and Aarti Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jindal Poly and Aarti Drugs

The main advantage of trading using opposite Jindal Poly and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jindal Poly position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.
The idea behind Jindal Poly Investment and Aarti Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance